152 related articles for article (PubMed ID: 1192959)
1. [Hemolytic disease of newborn].
Speilmann W
Dtsch Med Wochenschr; 1975 Sep; 100(38):1918. PubMed ID: 1192959
[No Abstract] [Full Text] [Related]
2. [The exchange transfusion in hemolytic disease of the newborn due to ABO-incompatibility].
Olearczyk J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):364-5. PubMed ID: 4193015
[No Abstract] [Full Text] [Related]
3. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
[No Abstract] [Full Text] [Related]
4. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
Kulich V; Sauer J
Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
[No Abstract] [Full Text] [Related]
5. Complement in ABO--hemolytic disease of the newborn.
Wang MY; Desforges JF
Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
[No Abstract] [Full Text] [Related]
6. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
Janovský M; Polácek K
Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
[No Abstract] [Full Text] [Related]
7. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
Cwik J
Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
[No Abstract] [Full Text] [Related]
8. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
Lange MM
Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
[No Abstract] [Full Text] [Related]
9. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
Kröger E; Scherbening G
Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
[No Abstract] [Full Text] [Related]
10. [Incidence of neonates treated with exchange transfusion for hemolytic disease due to ABO system incompatibility during the past 16 years].
Hodr R; Zoban P; Hromádková L; Kepertová M; Skutilová J
Cesk Pediatr; 1987 Aug; 42(8):464-6. PubMed ID: 3664755
[No Abstract] [Full Text] [Related]
11. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
Trifan N; Lupaşcu G; Trifan E
Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
[No Abstract] [Full Text] [Related]
12. [Icterus gravis and exchange transfusion].
Tulzer W; Griebler T
Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
[No Abstract] [Full Text] [Related]
13. [The rule of transfusional ABO compatibility in the neonatal period].
Sender A; Maigret P; Poulain M; Boeswillwald M; Lepage F
Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(5):560-1. PubMed ID: 5170679
[No Abstract] [Full Text] [Related]
14. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
Stegagno G; Mencarini L; Orvieto G
Minerva Pediatr; 1968 Oct; 20(41):2131-42. PubMed ID: 5754726
[No Abstract] [Full Text] [Related]
15. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
Di Piero G; Mencarini L; Ottaviano S; Lapi AS
Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
[No Abstract] [Full Text] [Related]
16. [Causes of regression in the exchange transfusion of newborn infants in Styria].
Rosegger VH; Teubl I; Stern E; Müller WD; Haidvogl M
Wien Med Wochenschr; 1978 May; 128(10):298-301. PubMed ID: 96610
[No Abstract] [Full Text] [Related]
17. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
Osborn LM; Lenarsky C; Oakes RC; Reiff MI
Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
[TBL] [Abstract][Full Text] [Related]
18. [Use of AB substance for the exsanguination transfusion in ABO system incompatibility].
Ruttkay F; Fabian P; Calkovská Z
Cesk Pediatr; 1972 Nov; 27(11):554-5. PubMed ID: 4673826
[No Abstract] [Full Text] [Related]
19. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
Hodr R; Vondrácek J; Skutilová J
Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
[No Abstract] [Full Text] [Related]
20. Transfusion support in the management of immune haemolytic disorders.
Plapp FV; Beck ML
Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
